Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Natalie A. Lockney

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2563-8081; OpenAlex author ID A5019128623. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: 1 paper

Papers 3

  1. Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s12029-015-9764-6↗
  2. Pattern of breast cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e318287885c↗
  3. 53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma. Co-author DOI 10.1186/1471-2407-13-155↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fen Xia · 3 shared papers, 2013–2015 · strength 0.12
  2. Nipun B. Merchant · 3 shared papers, 2013–2015 · strength 0.12
  3. A. Bapsi Chakravarthy · 3 shared papers, 2013–2015 · strength 0.12
  4. Sabrina C. Wentz · 2 shared papers, 2013 · strength 0.07
  5. Tong Wang · 2 shared papers, 2013 · strength 0.07
  6. Sabrina C. Sopha · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.